As Array Biopharma (ARRY) Stock Price Rose, Cambiar Investors Has Cut Holding; Capital Investment Counsel Decreased Its Position in Exxon Mobil (XOM) by $633,871

April 20, 2018 - By Nellie Frank

Exxon Mobil Corporation (NYSE:XOM) Logo

Capital Investment Counsel Inc decreased its stake in Exxon Mobil Corp (XOM) by 5.23% based on its latest 2017Q4 regulatory filing with the SEC. Capital Investment Counsel Inc sold 7,637 shares as the company’s stock declined 12.23% with the market. The institutional investor held 138,513 shares of the integrated oil company at the end of 2017Q4, valued at $11.59 million, down from 146,150 at the end of the previous reported quarter. Capital Investment Counsel Inc who had been investing in Exxon Mobil Corp for a number of months, seems to be less bullish one the $336.41 billion market cap company. The stock increased 0.25% or $0.2 during the last trading session, reaching $79.42. About 11.29M shares traded. Exxon Mobil Corporation (NYSE:XOM) has declined 9.29% since April 20, 2017 and is downtrending. It has underperformed by 20.84% the S&P500.

Cambiar Investors Llc decreased its stake in Array Biopharma Inc (ARRY) by 19.53% based on its latest 2017Q4 regulatory filing with the SEC. Cambiar Investors Llc sold 123,057 shares as the company’s stock rose 29.01% while stock markets declined. The institutional investor held 507,070 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $6.49M, down from 630,127 at the end of the previous reported quarter. Cambiar Investors Llc who had been investing in Array Biopharma Inc for a number of months, seems to be less bullish one the $3.00B market cap company. The stock decreased 5.56% or $0.85 during the last trading session, reaching $14.44. About 2.90 million shares traded. Array BioPharma Inc. (NASDAQ:ARRY) has risen 68.58% since April 20, 2017 and is uptrending. It has outperformed by 57.03% the S&P500.

Investors sentiment decreased to 0.84 in 2017 Q4. Its down 0.01, from 0.85 in 2017Q3. It dived, as 48 investors sold XOM shares while 819 reduced holdings. 123 funds opened positions while 603 raised stakes. 2.17 billion shares or 1.92% more from 2.13 billion shares in 2017Q3 were reported. Zurcher Kantonalbank (Zurich Cantonalbank) holds 1.21% in Exxon Mobil Corporation (NYSE:XOM) or 1.62 million shares. Parallax Volatility Advisers Limited Partnership has invested 0.01% in Exxon Mobil Corporation (NYSE:XOM). Jfs Wealth Advsr Ltd Liability stated it has 49,431 shares. Blue Edge Limited Liability reported 50,257 shares. 190,353 were reported by Crestwood Advsrs Gru Ltd Company. Chesapeake Asset Mngmt Llc invested in 20,530 shares. Torray Ltd Liability Corporation accumulated 19,945 shares. Liberty Capital Management Inc accumulated 2,709 shares. Salem Capital Management holds 0.54% of its portfolio in Exxon Mobil Corporation (NYSE:XOM) for 12,610 shares. Hamlin Mgmt Llc owns 663,428 shares or 2.13% of their US portfolio. Appleton Prtnrs Ma has invested 0.87% in Exxon Mobil Corporation (NYSE:XOM). 61,729 are owned by Court Place Limited Liability Corp. Farmers State Bank accumulated 91,881 shares. Ironwood Fincl Ltd Liability, a Arizona-based fund reported 24 shares. Grassi Investment Management invested in 1.1% or 81,400 shares.

Among 26 analysts covering Exxon Mobil (NYSE:XOM), 10 have Buy rating, 6 Sell and 10 Hold. Therefore 38% are positive. Exxon Mobil had 91 analyst reports since July 22, 2015 according to SRatingsIntel. Piper Jaffray maintained Exxon Mobil Corporation (NYSE:XOM) rating on Thursday, October 5. Piper Jaffray has “Hold” rating and $76.0 target. BMO Capital Markets maintained it with “Hold” rating and $80.0 target in Wednesday, October 18 report. The firm has “Hold” rating given on Tuesday, January 23 by Piper Jaffray. The rating was maintained by Cowen & Co on Tuesday, September 19 with “Buy”. The rating was upgraded by Barclays Capital to “Overweight” on Tuesday, July 11. The stock of Exxon Mobil Corporation (NYSE:XOM) has “Market Perform” rating given on Thursday, March 8 by Wells Fargo. As per Monday, February 5, the company rating was maintained by Piper Jaffray. As per Monday, May 2, the company rating was maintained by Credit Suisse. The firm earned “Buy” rating on Friday, July 28 by Cowen & Co. As per Monday, June 5, the company rating was upgraded by Scotia Capital.

Analysts await Exxon Mobil Corporation (NYSE:XOM) to report earnings on April, 27 before the open. They expect $1.18 earnings per share, up 24.21% or $0.23 from last year’s $0.95 per share. XOM’s profit will be $5.00B for 16.83 P/E if the $1.18 EPS becomes a reality. After $0.88 actual earnings per share reported by Exxon Mobil Corporation for the previous quarter, Wall Street now forecasts 34.09% EPS growth.

Since December 11, 2017, it had 0 insider buys, and 4 selling transactions for $3.42 million activity. 7,281 shares valued at $606,082 were sold by Milton Bryan W on Tuesday, December 12. The insider Wascom Dennis G sold 2,412 shares worth $200,293. Shares for $996,628 were sold by Chapman Neil A on Thursday, December 14.

Since December 16, 2017, it had 0 buys, and 8 selling transactions for $15.94 million activity. Squarer Ron had sold 819,671 shares worth $8.90M on Saturday, December 16. Sandor Victor sold $133,376 worth of Array BioPharma Inc. (NASDAQ:ARRY) on Sunday, April 1. 21,500 shares were sold by VAN LUNSEN GIL J, worth $360,340 on Wednesday, March 21. Haddock Jason sold $102,975 worth of stock or 7,500 shares.

Analysts await Array BioPharma Inc. (NASDAQ:ARRY) to report earnings on May, 9. They expect $-0.22 earnings per share, down 4.76% or $0.01 from last year’s $-0.21 per share. After $-0.17 actual earnings per share reported by Array BioPharma Inc. for the previous quarter, Wall Street now forecasts 29.41% negative EPS growth.

Cambiar Investors Llc, which manages about $8.42B and $6.39 billion US Long portfolio, upped its stake in Smith & Nephew Plc (NYSE:SNN) by 537,369 shares to 5.94 million shares, valued at $207.80M in 2017Q4, according to the filing. It also increased its holding in Ambev Sa (NYSE:ABEV) by 294,358 shares in the quarter, for a total of 21.54M shares, and has risen its stake in Xl Group Ltd.

Exxon Mobil Corporation (NYSE:XOM) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>